Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Net Income (2020 - 2025)

Historic Net Income for IDEAYA Biosciences (IDYA) over the last 6 years, with Q3 2025 value amounting to $108.5 million.

  • IDEAYA Biosciences' Net Income rose 26212.76% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.7 million, marking a year-over-year increase of 8412.22%. This contributed to the annual value of -$327.0 million for FY2024, which is 14323.25% down from last year.
  • IDEAYA Biosciences' Net Income amounted to $108.5 million in Q3 2025, which was up 26212.76% from -$144.1 million recorded in Q4 2024.
  • In the past 5 years, IDEAYA Biosciences' Net Income registered a high of $108.5 million during Q3 2025, and its lowest value of -$144.1 million during Q4 2024.
  • In the last 5 years, IDEAYA Biosciences' Net Income had a median value of -$26.3 million in 2023 and averaged -$27.4 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Net Income tumbled by 517969.7% in 2023 and then surged by 26212.76% in 2025.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Net Income stood at -$18.4 million in 2021, then crashed by 43.95% to -$26.4 million in 2022, then plummeted by 58.52% to -$41.9 million in 2023, then plummeted by 243.87% to -$144.1 million in 2024, then surged by 175.24% to $108.5 million in 2025.
  • Its Net Income stands at $108.5 million for Q3 2025, versus -$144.1 million for Q4 2024 and -$66.9 million for Q3 2024.